| 注册
首页|期刊导航|中国药物评价|帕罗西汀治疗躯体形式障碍的系统评价

帕罗西汀治疗躯体形式障碍的系统评价

杨红双 马爱霞

中国药物评价Issue(4):232-236,5.
中国药物评价Issue(4):232-236,5.

帕罗西汀治疗躯体形式障碍的系统评价

Systematic Review of Paroxetine in the Treatment of Somatization Disorder

杨红双 1马爱霞1

作者信息

  • 1. 中国药科大学国际医药商学院,江苏南京211198
  • 折叠

摘要

Abstract

Objective:To study the efficacy and side effect of Paroxetine in the treatment of somatization disorder.Methods:13 com-parative studies of Paroxetine and other antidepressants in the treatment of somatization disorder were analyzed by meta -ananlysis.Re-sults:We included 13 studies with 723 patients.Four treatment period subgroups were created:2, 4, 6 and 8 weeks.In the 2-week sub-group, paroxetine was more efficacious than controlled group [MD=-2.10,95%CI(-3.52,-0.67),P=0.004].In the 4-week sub-group, paroxetine was more efficacious than controlled group [MD=-1.36,95%CI(-2.38,-0.33),P=0.009].In the 6-week sub-group, two drugs displayed comparative efficacy [ MD=-0.76 ,95%CI ( -1.87 ,-0.35 ) , P=0.18 ].In the 8-week subgroup , two drugs displayed comparative efficacy [MD=-0.50,95%CI( -1.32,-0.32),P=0.23].There were no significant differences in safety [ MD=-1.35 ,95%CI ( -6.77 ,-4.08 ].Conclusion: Paroxetine had a similar treatment effect and side effect to other con-trolled antidepressants.But Paroxetine had a earlier effect.It can improve the symptoms of somatoform disorder patients earlier.

关键词

帕罗西汀/躯体形式障碍/Meta分析

Key words

Paroxetine/Somatization disorder/Meta-ananlysis

分类

医药卫生

引用本文复制引用

杨红双,马爱霞..帕罗西汀治疗躯体形式障碍的系统评价[J].中国药物评价,2014,(4):232-236,5.

中国药物评价

2095-3593

访问量0
|
下载量0
段落导航相关论文